drugset / Trial / NCT02432027

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

NCT02432027

Phase 1/2 Completed 14 enrolled Prism Pharma Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluate the effects of topical C-82 in a psoriasis plaque test.

Timeline

Start
2015-06
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject C-82 Unknown 1 % Topical
Comparator Calcipotriol Small molecule 50 unknown
Comparator Diprosis Unknown 0.5 unknown

Indications